B101 PHENOTYPING OF ASTHMA IN THE ERA OF BIOMARKERS AND OMICS: High Blood Eosinophil Concentrations And Serum Biomarkers Of Low Il-13 Pathway Activation At Baseline Predict Exacerbation Rate Reduction By Benralizumab For Patients With Moderate To Severe Asthma

B101 PHENOTYPING OF ASTHMA IN THE ERA OF BIOMARKERS AND OMICS: High Blood Eosinophil Concentrations And Serum Biomarkers Of Low Il-13 Pathway Activation At Baseline Predict Exacerbation Rate Reduction By Benralizumab For Patients With Moderate To Severe Asthma

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2016-01, Vol.193, p.1
Hauptverfasser: Newbold, P, Wu, Y, Shih, V, Liang, M, Vainshtein, I, Ranade, K
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1073-449X
1535-4970